imiquimod has been researched along with Leishmaniasis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coimbra, ES; da Silva, AD; Dib, PRB; Fung, J; Granato, JT; Kaushik, D; Macedo, GC; Petrovsky, N; Piplani, S; Salunke, DB | 1 |
| Loughlin, WA; Reynolds, KA; Young, DJ | 1 |
| Dobakhti, F; Khalili, G; Khaze, V; Mahmoudzadeh-Niknam, H; Partovi, F | 1 |
| Berman, J | 1 |
| Buates, S; Matlashewski, G | 1 |
2 review(s) available for imiquimod and Leishmaniasis
| Article | Year |
|---|---|
Quinolines as chemotherapeutic agents for leishmaniasis.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Imiquimod; Leishmania; Leishmaniasis; Primaquine; Quinolines; Structure-Activity Relationship | 2013 |
Clinical status of agents being developed for leishmaniasis.
Topics: Aminoquinolines; Antiprotozoal Agents; Fluconazole; Humans; Imiquimod; Ketoconazole; Leishmaniasis; Paromomycin; Phosphorylcholine | 2005 |
3 other study(ies) available for imiquimod and Leishmaniasis
| Article | Year |
|---|---|
Toll-like receptor-7/8 agonist kill Leishmania amazonensis by acting as pro-oxidant and pro-inflammatory agent.
Topics: Animals; Antiprotozoal Agents; Cytokines; Female; Humans; Imidazoles; Imiquimod; Inflammation; Leishmania; Leishmaniasis; Macrophages, Peritoneal; Mice, Inbred BALB C; Nitric Oxide; Reactive Oxygen Species; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2021 |
Immunotherapy with Imiquimod increases the efficacy of Glucantime therapy of Leishmania major infection.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Antiprotozoal Agents; Drug Therapy, Combination; Imiquimod; Immunotherapy; Leishmania major; Leishmaniasis; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Treatment Outcome | 2011 |
Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action.
Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Bone Marrow Cells; Female; Imiquimod; Leishmania donovani; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-fos; Signal Transduction; Trypanocidal Agents | 1999 |